Loading…

Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study

Objectives. Magnetic resonance spectroscopy (MRS) allows the contents of many metabolites in living tissues to be assessed. There is a good number of studies analyzing MRS data in Alzheimer’s disease (AD), though their results are contradictory. In this regard, there is value in comparing MRS data w...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience and behavioral physiology 2019-11, Vol.49 (9), p.1199-1207
Main Authors: Khomenko, Yu. G., Kataeva, G. V., Bogdan, A. A., Chernysheva, E. M., Susin, D. S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933
cites cdi_FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933
container_end_page 1207
container_issue 9
container_start_page 1199
container_title Neuroscience and behavioral physiology
container_volume 49
creator Khomenko, Yu. G.
Kataeva, G. V.
Bogdan, A. A.
Chernysheva, E. M.
Susin, D. S.
description Objectives. Magnetic resonance spectroscopy (MRS) allows the contents of many metabolites in living tissues to be assessed. There is a good number of studies analyzing MRS data in Alzheimer’s disease (AD), though their results are contradictory. In this regard, there is value in comparing MRS data with fluorodeoxyglucose (FDG) positron emission tomography (PET) results, which assess the functional state of nervous tissue. The present study provides a comparison of MRI scan data in AD and moderate cognitive impairment (MCI) with the characteristics of cerebral glucose metabolism assessed from FDG-PET data. Materials and methods. Multivoxel proton MRS of the supraventricular region was carried out in patients with AD ( n = 16) and MCI ( n = 14). The following metabolite ratios were determined: NAA/Cr, Cho/Cr, and NAA/Cho (NAA is N-acetylaspartate, Cr is creatine, and Cho is choline). Patients underwent neurological investigation, assessment of cognitive status, and PET scans with FDG. Results. Patients with AD showed decreases in NAA/Cr and Cho/Cr in the white matter of the medial cortex of the supraventricular areas of both hemispheres. The MCI group showed a decrease in the NAA/Cr ratio in only one area of the white matter of the left hemisphere, adjacent to the parietal cortex. Positive correlations were found between NAA/Cr and Cho/Cr with measures of cognitive status and with the rate of glucose metabolism measured from PET data in the frontal, parietal, and temporal areas and the cingulate cortex. Conclusions. The decrease in the NAA/Cr ratio in the supraventricular white matter and the medial cortex in AD and the correlation of this parameter with cognitive test results and cerebral glucose metabolism constitute evidence that it may have diagnostic value, reflecting the severity of cognitive impairments. Assessment of the NAA/Cr ratio should be carried out with consideration of the fact that dementia alters the concentrations of both metabolites (NAA and Cr).
doi_str_mv 10.1007/s11055-019-00858-1
format article
fullrecord <record><control><sourceid>crossref_sprin</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s11055_019_00858_1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1007_s11055_019_00858_1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933</originalsourceid><addsrcrecordid>eNp9kE1OwzAQRi0EEqVwAVa-QMBOmjhmh0L5kaioaJHYRY49SV01dmS7oJyBS2Moa1Yz-jRvNPMQuqTkihLCrj2lJM8TQnlCSJmXCT1CE5qzLCk5fz9GE0I4S0g-46fozPstiRAryQR9VeCgcWKHFxBEY3fa91gbvBRBgwkef-qwwZXtjA76A_Cd9tYpcP4Gixj3jTag8EJ0BoKW-BW8NcJIwKsBZHDWSzuMWBiFl9brGBg877X3OjZr29vOiWEz4lXYq_EcnbRi5-Hir07R2_18XT0mzy8PT9XtcyJTUtCkaNqmpYRlisUf2lmjQJSF4q0sClbkjFGREwqNErJJVVoILiQrM8iYKPmMZ9kUpYe9Mt7nHbT14HQv3FhTUv_orA8666iz_tVZ0whlB8jHYdOBq7d270y88z_qG_zte-s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study</title><source>Springer Link</source><creator>Khomenko, Yu. G. ; Kataeva, G. V. ; Bogdan, A. A. ; Chernysheva, E. M. ; Susin, D. S.</creator><creatorcontrib>Khomenko, Yu. G. ; Kataeva, G. V. ; Bogdan, A. A. ; Chernysheva, E. M. ; Susin, D. S.</creatorcontrib><description>Objectives. Magnetic resonance spectroscopy (MRS) allows the contents of many metabolites in living tissues to be assessed. There is a good number of studies analyzing MRS data in Alzheimer’s disease (AD), though their results are contradictory. In this regard, there is value in comparing MRS data with fluorodeoxyglucose (FDG) positron emission tomography (PET) results, which assess the functional state of nervous tissue. The present study provides a comparison of MRI scan data in AD and moderate cognitive impairment (MCI) with the characteristics of cerebral glucose metabolism assessed from FDG-PET data. Materials and methods. Multivoxel proton MRS of the supraventricular region was carried out in patients with AD ( n = 16) and MCI ( n = 14). The following metabolite ratios were determined: NAA/Cr, Cho/Cr, and NAA/Cho (NAA is N-acetylaspartate, Cr is creatine, and Cho is choline). Patients underwent neurological investigation, assessment of cognitive status, and PET scans with FDG. Results. Patients with AD showed decreases in NAA/Cr and Cho/Cr in the white matter of the medial cortex of the supraventricular areas of both hemispheres. The MCI group showed a decrease in the NAA/Cr ratio in only one area of the white matter of the left hemisphere, adjacent to the parietal cortex. Positive correlations were found between NAA/Cr and Cho/Cr with measures of cognitive status and with the rate of glucose metabolism measured from PET data in the frontal, parietal, and temporal areas and the cingulate cortex. Conclusions. The decrease in the NAA/Cr ratio in the supraventricular white matter and the medial cortex in AD and the correlation of this parameter with cognitive test results and cerebral glucose metabolism constitute evidence that it may have diagnostic value, reflecting the severity of cognitive impairments. Assessment of the NAA/Cr ratio should be carried out with consideration of the fact that dementia alters the concentrations of both metabolites (NAA and Cr).</description><identifier>ISSN: 0097-0549</identifier><identifier>EISSN: 1573-899X</identifier><identifier>DOI: 10.1007/s11055-019-00858-1</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Behavioral Sciences ; Biomedical and Life Sciences ; Biomedicine ; Neurobiology ; Neurosciences</subject><ispartof>Neuroscience and behavioral physiology, 2019-11, Vol.49 (9), p.1199-1207</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933</citedby><cites>FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Khomenko, Yu. G.</creatorcontrib><creatorcontrib>Kataeva, G. V.</creatorcontrib><creatorcontrib>Bogdan, A. A.</creatorcontrib><creatorcontrib>Chernysheva, E. M.</creatorcontrib><creatorcontrib>Susin, D. S.</creatorcontrib><title>Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study</title><title>Neuroscience and behavioral physiology</title><addtitle>Neurosci Behav Physi</addtitle><description>Objectives. Magnetic resonance spectroscopy (MRS) allows the contents of many metabolites in living tissues to be assessed. There is a good number of studies analyzing MRS data in Alzheimer’s disease (AD), though their results are contradictory. In this regard, there is value in comparing MRS data with fluorodeoxyglucose (FDG) positron emission tomography (PET) results, which assess the functional state of nervous tissue. The present study provides a comparison of MRI scan data in AD and moderate cognitive impairment (MCI) with the characteristics of cerebral glucose metabolism assessed from FDG-PET data. Materials and methods. Multivoxel proton MRS of the supraventricular region was carried out in patients with AD ( n = 16) and MCI ( n = 14). The following metabolite ratios were determined: NAA/Cr, Cho/Cr, and NAA/Cho (NAA is N-acetylaspartate, Cr is creatine, and Cho is choline). Patients underwent neurological investigation, assessment of cognitive status, and PET scans with FDG. Results. Patients with AD showed decreases in NAA/Cr and Cho/Cr in the white matter of the medial cortex of the supraventricular areas of both hemispheres. The MCI group showed a decrease in the NAA/Cr ratio in only one area of the white matter of the left hemisphere, adjacent to the parietal cortex. Positive correlations were found between NAA/Cr and Cho/Cr with measures of cognitive status and with the rate of glucose metabolism measured from PET data in the frontal, parietal, and temporal areas and the cingulate cortex. Conclusions. The decrease in the NAA/Cr ratio in the supraventricular white matter and the medial cortex in AD and the correlation of this parameter with cognitive test results and cerebral glucose metabolism constitute evidence that it may have diagnostic value, reflecting the severity of cognitive impairments. Assessment of the NAA/Cr ratio should be carried out with consideration of the fact that dementia alters the concentrations of both metabolites (NAA and Cr).</description><subject>Behavioral Sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Neurobiology</subject><subject>Neurosciences</subject><issn>0097-0549</issn><issn>1573-899X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQRi0EEqVwAVa-QMBOmjhmh0L5kaioaJHYRY49SV01dmS7oJyBS2Moa1Yz-jRvNPMQuqTkihLCrj2lJM8TQnlCSJmXCT1CE5qzLCk5fz9GE0I4S0g-46fozPstiRAryQR9VeCgcWKHFxBEY3fa91gbvBRBgwkef-qwwZXtjA76A_Cd9tYpcP4Gixj3jTag8EJ0BoKW-BW8NcJIwKsBZHDWSzuMWBiFl9brGBg877X3OjZr29vOiWEz4lXYq_EcnbRi5-Hir07R2_18XT0mzy8PT9XtcyJTUtCkaNqmpYRlisUf2lmjQJSF4q0sClbkjFGREwqNErJJVVoILiQrM8iYKPmMZ9kUpYe9Mt7nHbT14HQv3FhTUv_orA8666iz_tVZ0whlB8jHYdOBq7d270y88z_qG_zte-s</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Khomenko, Yu. G.</creator><creator>Kataeva, G. V.</creator><creator>Bogdan, A. A.</creator><creator>Chernysheva, E. M.</creator><creator>Susin, D. S.</creator><general>Springer US</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20191101</creationdate><title>Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study</title><author>Khomenko, Yu. G. ; Kataeva, G. V. ; Bogdan, A. A. ; Chernysheva, E. M. ; Susin, D. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Behavioral Sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Neurobiology</topic><topic>Neurosciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khomenko, Yu. G.</creatorcontrib><creatorcontrib>Kataeva, G. V.</creatorcontrib><creatorcontrib>Bogdan, A. A.</creatorcontrib><creatorcontrib>Chernysheva, E. M.</creatorcontrib><creatorcontrib>Susin, D. S.</creatorcontrib><collection>CrossRef</collection><jtitle>Neuroscience and behavioral physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khomenko, Yu. G.</au><au>Kataeva, G. V.</au><au>Bogdan, A. A.</au><au>Chernysheva, E. M.</au><au>Susin, D. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study</atitle><jtitle>Neuroscience and behavioral physiology</jtitle><stitle>Neurosci Behav Physi</stitle><date>2019-11-01</date><risdate>2019</risdate><volume>49</volume><issue>9</issue><spage>1199</spage><epage>1207</epage><pages>1199-1207</pages><issn>0097-0549</issn><eissn>1573-899X</eissn><abstract>Objectives. Magnetic resonance spectroscopy (MRS) allows the contents of many metabolites in living tissues to be assessed. There is a good number of studies analyzing MRS data in Alzheimer’s disease (AD), though their results are contradictory. In this regard, there is value in comparing MRS data with fluorodeoxyglucose (FDG) positron emission tomography (PET) results, which assess the functional state of nervous tissue. The present study provides a comparison of MRI scan data in AD and moderate cognitive impairment (MCI) with the characteristics of cerebral glucose metabolism assessed from FDG-PET data. Materials and methods. Multivoxel proton MRS of the supraventricular region was carried out in patients with AD ( n = 16) and MCI ( n = 14). The following metabolite ratios were determined: NAA/Cr, Cho/Cr, and NAA/Cho (NAA is N-acetylaspartate, Cr is creatine, and Cho is choline). Patients underwent neurological investigation, assessment of cognitive status, and PET scans with FDG. Results. Patients with AD showed decreases in NAA/Cr and Cho/Cr in the white matter of the medial cortex of the supraventricular areas of both hemispheres. The MCI group showed a decrease in the NAA/Cr ratio in only one area of the white matter of the left hemisphere, adjacent to the parietal cortex. Positive correlations were found between NAA/Cr and Cho/Cr with measures of cognitive status and with the rate of glucose metabolism measured from PET data in the frontal, parietal, and temporal areas and the cingulate cortex. Conclusions. The decrease in the NAA/Cr ratio in the supraventricular white matter and the medial cortex in AD and the correlation of this parameter with cognitive test results and cerebral glucose metabolism constitute evidence that it may have diagnostic value, reflecting the severity of cognitive impairments. Assessment of the NAA/Cr ratio should be carried out with consideration of the fact that dementia alters the concentrations of both metabolites (NAA and Cr).</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s11055-019-00858-1</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0097-0549
ispartof Neuroscience and behavioral physiology, 2019-11, Vol.49 (9), p.1199-1207
issn 0097-0549
1573-899X
language eng
recordid cdi_crossref_primary_10_1007_s11055_019_00858_1
source Springer Link
subjects Behavioral Sciences
Biomedical and Life Sciences
Biomedicine
Neurobiology
Neurosciences
title Cerebral Metabolism in Patients with Cognitive Disorders: a Combined Magnetic Resonance Spectroscopy and Positron Emission Tomography Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T01%3A20%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebral%20Metabolism%20in%20Patients%20with%20Cognitive%20Disorders:%20a%20Combined%20Magnetic%20Resonance%20Spectroscopy%20and%20Positron%20Emission%20Tomography%20Study&rft.jtitle=Neuroscience%20and%20behavioral%20physiology&rft.au=Khomenko,%20Yu.%20G.&rft.date=2019-11-01&rft.volume=49&rft.issue=9&rft.spage=1199&rft.epage=1207&rft.pages=1199-1207&rft.issn=0097-0549&rft.eissn=1573-899X&rft_id=info:doi/10.1007/s11055-019-00858-1&rft_dat=%3Ccrossref_sprin%3E10_1007_s11055_019_00858_1%3C/crossref_sprin%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2061-6bfbf1073d7778f4bdea86d9fc66765771a501ebdacb2d26a9ac783e37a894933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true